Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Name: Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
Published: 2021
License: Public Domain

R-Pharm International, LLC · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

interleukin

familial mediterranean fever, fmf, rph-104, colchicine inefficacy, colchicine intolerance, colchicine resistance, subcutaneous, interleukin-1 inhibitor, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Related documents